Close Menu

NEW YORK (360Dx) – The fecal immunochemical test could help diagnose patients with colorectal cancer whose initial symptoms are equivocal, according to a new study.

About half of colorectal cancer patients present with symptoms that are also often associated with benign conditions. As opposed to more alarming symptoms that get patients sent off quickly for colonoscopy, these low-risk, or "non-alarm," symptoms more often trigger a "wait and see" approach, the authors of the new study said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.